INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 435m ago
HOUSE PTR35m ago
SEC 13F35m ago
ROBINHOOD CHAIN35m ago
Public company

IRMDIRADIMED CORP

CIK 0001325618

EDGAR filingsOpen in network
Disclosed transactions25
Buys / sells0 / 16
Max Insider Score32
Connections4with evidence

IRMD · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Open-market sale
SELL$168K
1,766 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Insider ofevidence
    Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner · Dec 30, 2025
  • ← Insider ofevidence
    Chiprin JeffChief Commercial Officer · Dec 12, 2025
  • ← Insider ofevidence
    Scharen-Guivel Hilda FrederiqueDirector · Dec 9, 2025
28
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Open-market sale
SELL
$117K
1,234 sh
Jun 4, 2026
Jun 4, 2026
traded Jun 4, 2026
+0d
SEC FORM 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$238K
2,564 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$170K
1,847 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$55K
589 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$197K
2,107 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC FORM 4

Evidence

0
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$37K
393 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC FORM 4

Evidence

17
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$92K
915 sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC FORM 4

Evidence

20
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$76K
750 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC FORM 4

Evidence

20
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$133K
1,300 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC FORM 4

Evidence

17
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$159K
1,585 sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC FORM 4

Evidence

23
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$294K
2,950 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC FORM 4

Evidence

9
CJ
Chiprin JeffChief Commercial Officer
IRMDIRADIMED CORP
Grant or award
A—
1,150 sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

17
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$11K
112 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

23
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$476K
4,888 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

21
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$9,929
101 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC FORM 4

Evidence

27
SE
Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner
IRMDIRADIMED CORP
Open-market sale
SELL$478K
4,899 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC FORM 4

Evidence

21
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Grant or award
A—
1,026 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

21
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Option exercise
M—
905 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

21
CJ
Chiprin JeffChief Commercial Officer
IRMDIRADIMED CORP
Option exercise
M—
996 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

13
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Option exercise
M—
905 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

9
CJ
Chiprin JeffChief Commercial Officer
IRMDIRADIMED CORP
Option exercise
M—
996 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

21
CJ
Chiprin JeffChief Commercial Officer
IRMDIRADIMED CORP
Tax withholding
F$30K
309 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

9
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Option exercise
M—
1,197 sh
Dec 7, 2025Dec 9, 2025
traded Dec 7, 2025
+2dSEC FORM 4

Evidence

13
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Option exercise
M—
1,197 sh
Dec 7, 2025Dec 9, 2025
traded Dec 7, 2025
+2dSEC FORM 4

Evidence